bruce linton
Creso shifts gears
Mr Lay and Mr Linton worked closely together during their time at Canopy Growth, assessing, overseeing and executing over C$5Bn in cannabis transactions, including the industry’s largest acquisition to date.
bruce linton
Mr Lay and Mr Linton worked closely together during their time at Canopy Growth, assessing, overseeing and executing over C$5Bn in cannabis transactions, including the industry’s largest acquisition to date.
creso
Creso Pharma Limited (ASX:CPH, FRA:1X8) gave an update on target acquisition company, Halucenex Life Sciences (“Halucenex”).